This inventor holds 3 USPTO granted patents. Top assignee: Hercules Corporation. Active years: 2002-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2003
Title: Simon Delagrave: Innovator in Polynucleotide Assembly
Introduction
Simon Delagrave is a notable inventor based in Avondale, PA (US). He has made significant contributions to the field of biotechnology, particularly in the area of polynucleotide assembly. With a total of 3 patents to his name, Delagrave's work has the potential to impact various applications in genetic engineering and molecular biology.
Latest Patents
Delagrave's latest patents include innovative methods for the enzymatic assembly of polynucleotides. One of his inventions provides methods for preparing large polynucleotides of arbitrary sequence, which can be automated for efficiency. This invention allows for the creation of polynucleotides with at least 200 nucleotides by ligating multiple oligonucleotides, thus representing the desired nucleotide sequence. Additionally, he has developed libraries of polynucleotides and methods for screening these libraries to identify members with specific properties. Another significant patent involves variant galactose oxidase enzymes, which includes mutant genes, constructs, and recombinant host cells. This invention also encompasses the vGO polypeptides and antibodies, along with methods for their production and application.
Career Highlights
Simon Delagrave is currently associated with Hercules Corporation, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the biotechnology sector, contributing to innovative solutions that address complex challenges in genetic research.
Collaborations
Delagrave has collaborated with notable colleagues, including Anthony M Maffia, III and Dennis Murphy. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in their field.
Conclusion
In summary, Simon Delagrave is a distinguished inventor whose work in polynucleotide assembly and enzymatic processes is paving the way for advancements in biotechnology. His contributions are not only innovative but also essential for future developments in genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile